Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 25, 2024
- Accepted for publication October 22, 2024
- Published online December 3, 2024.
Article Versions
- previous version (November 14, 2024 - 06:40).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2024 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions.
Author Information
- 1Division of Hematology/Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia; and
- 2Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Virginia
- For correspondence or reprints, contact Elizabeth M. Gaughan (emg5x{at}UVAhealth.org).
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
- Article
- Abstract
- EPIDEMIOLOGY
- STAGING OF DISEASE AT TIME OF DIAGNOSIS
- MANAGEMENT OF PRIMARY CUTANEOUS MELANOMA
- MOLECULAR PROFILING AND TARGETED THERAPIES
- IMMUNOTHERAPY AND IMMUNE CHECKPOINT INHIBITION
- IMMUNE CHECKPOINT INHIBITION IN METASTATIC MELANOMA
- ADJUVANT IMMUNE CHECKPOINT INHIBITION
- NEOADJUVANT IMMUNE CHECKPOINT INHIBITION
- IMAGING SURVEILLANCE OF CUTANEOUS MELANOMA
- FUTURE OF RADIOLOGY IN MELANOMA
- Footnotes
- REFERENCES
- Figures & Data
- Info & Metrics
Related Articles
Cited By...
- No citing articles found.